5TY-31974-08812 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-06
Dose 1 — Pfizer-BioNTech
2021-03-31
Dose 2 — Pfizer-BioNTech
2021-12-09
Dose 3 — Pfizer-BioNTech
2021-12-10
Registered in v-safe
2021-12-10
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Redness, Itching · Headache, Muscle or body aches, Nausea · Be unable to do your normal daily activities

Adult check-in
2021-12-12
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-12-14
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-12-23
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2022-01-02
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2022-01-13
Survey response — day 35, dose 3
MedDRA: Rhinorrhoea, Sinus congestion — Feeling: Fair · Be unable to do your normal daily activities

Free text: Sinus congestion, runny nose

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-06	Pfizer-BioNTech	No
2	2021-03-31	Pfizer-BioNTech	No
3	2021-12-09	Pfizer-BioNTech	No

Free text

Release 10 — day 35, dose 3

2022-01-13

Symptoms: Sinus congestion, runny nose

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Rhinorrhoea	·	·	✓
SD	Sinus congestion	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release